MedPath

Vitiligo and Hair Autograft

Phase 2
Conditions
Vitiligo.
Vitiligo
Registration Number
IRCT138812183310N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Segmental vitiligo patients with no response to other treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Appearance of spots of Repigmentation. Timepoint: after 4, 8 and 12 weeks. Method of measurement: Observing the size and shape.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath